'Neuroendocrine tumour (NET)' clinical trials
Search results
-
This trial is looking at everolimus (Afinitor) to treat neuroendocrine tumours (NETs) of the digestive system or lungs.…
-
This study is looking at body fluid samples and heart ultrasound scans (echocardiograms) to learn more about heart disease caused by carcinoid tumours.…
-
This study is looking at genes in people with a neuroendocrine tumour to see if the information they collect can one day help improve treatment for these conditions.…
-
This study is trying to find genes that may be important in the development of tumours in the pituitary gland.…
-
This study will develop a questionnaire looking at quality of life for people having treatment for carcinoid or neuroendocrine tumours (NET).…
-
This trial will compare capecitabine (Xeloda) and streptozocin with capecitabine, streptozocin and cisplatin for people with neuroendocrine tumours.…
-
A trial looking at lanreotide autogel for neuroendocrine tumours of the digestive system that have spread.…
-
This study is looking for cancer cells in the bloodstreams of people with neuroendocrine tumours (NETs).…
-
This trial is looking at a new drug called pasireotide to see if it controls symptoms of carcinoid syndrome.…
-
This trial is looking at using everolimus (Afinitor, RAD001) in combination with a new drug called pasireotide for people with neuroendocrine tumours of the pancreas.…
These trials are recruiting patients
These trials are no longer recruiting patients
Go back to the basic trials search or the advanced trials search.







Read article 

